PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
94.72
+2.02 (2.18%)
Nov 21, 2024, 12:44 PM EST - Market open
PROCEPT BioRobotics Employees
PROCEPT BioRobotics had 626 employees as of December 31, 2023. The number of employees increased by 198 or 46.26% compared to the previous year.
Employees
626
Change (1Y)
198
Growth (1Y)
46.26%
Revenue / Employee
$319,238
Profits / Employee
-$159,842
Market Cap
5.12B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 626 | 198 | 46.26% |
| Dec 31, 2022 | 428 | 194 | 82.91% |
| Dec 31, 2021 | 234 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Select Medical Holdings | 54,600 |
| Stevanato Group | 5,634 |
| Inspire Medical Systems | 1,011 |
| Lantheus Holdings | 834 |
| ADMA Biologics | 624 |
| Crinetics Pharmaceuticals | 290 |
| Avidity Biosciences | 253 |
| Biohaven | 239 |
PRCT News
- 22 days ago - PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock - GlobeNewsWire
- 23 days ago - PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock - GlobeNewsWire
- 23 days ago - Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential - Benzinga
- 24 days ago - PROCEPT BioRobotics Corporation (PRCT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 24 days ago - PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance - GlobeNewsWire
- 6 weeks ago - PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024 - GlobeNewsWire
- 6 weeks ago - PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer - GlobeNewsWire
- 3 months ago - PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024 - GlobeNewsWire